S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: clodronate disodium|DRUG: ibandronate sodium|DRUG: zoledronic acid
Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)|North Central Cancer Treatment Group|Eastern Cooperative Oncology Group|NSABP Foundation Inc|Cancer and Leukemia Group B|NCIC Clinical Trials Group